Anna Legedza is a seasoned professional in biostatistics, currently serving as Senior Director of Biostatistics at Mediar Therapeutics since August 2025. Anna has an extensive background in the field, having previously held leadership positions at Lyndra Therapeutics and Alkermes, where Anna served as Director of Biostatistics. Anna's experience at Vertex Pharmaceuticals spanned nearly a decade, involving roles from Senior Biostatistician to Associate Director. Earlier in the career, Anna worked as an Associate Biostatistician at Beth Israel Deaconess Medical Center and as a staff consultant at PwC. In addition to a distinguished career in biostatistics, Anna was also a violinist and former board member of the Longwood Symphony Orchestra for three decades. Anna's education includes a postdoctoral fellowship and a Doctor of Science in Biostatistics from Harvard T.H. Chan School of Public Health, as well as a Master's in Statistics from Carnegie Mellon University and an A.B. in Mathematics from Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices